These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30819613)

  • 1. The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier.
    Hordeaux J; Yuan Y; Clark PM; Wang Q; Martino RA; Sims JJ; Bell P; Raymond A; Stanford WL; Wilson JM
    Mol Ther; 2019 May; 27(5):912-921. PubMed ID: 30819613
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
    Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.
    Huang Q; Chan KY; Tobey IG; Chan YA; Poterba T; Boutros CL; Balazs AB; Daneman R; Bloom JM; Seed C; Deverman BE
    PLoS One; 2019; 14(11):e0225206. PubMed ID: 31725765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice.
    Xie BS; Wang X; Pan YH; Jiang G; Feng JF; Lin Y
    Theranostics; 2021; 11(3):1177-1191. PubMed ID: 33391529
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein LY6E as a candidate for mediating transport of adeno-associated virus across the human blood-brain barrier.
    Ille AM; Kishel E; Bodea R; Ille A; Lamont H; Amico-Ruvio S
    J Neurovirol; 2020 Oct; 26(5):769-778. PubMed ID: 32839948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
    Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
    J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
    Dayton RD; Grames MS; Klein RL
    Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
    Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
    Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice.
    Davidson CD; Gibson AL; Gu T; Baxter LL; Deverman BE; Beadle K; Incao AA; Rodriguez-Gil JL; Fujiwara H; Jiang X; Chandler RJ; Ory DS; Gradinaru V; Venditti CP; Pavan WJ
    Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34407999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy.
    Morabito G; Giannelli SG; Ordazzo G; Bido S; Castoldi V; Indrigo M; Cabassi T; Cattaneo S; Luoni M; Cancellieri C; Sessa A; Bacigaluppi M; Taverna S; Leocani L; Lanciego JL; Broccoli V
    Mol Ther; 2017 Dec; 25(12):2727-2742. PubMed ID: 28882452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
    Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
    Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice.
    Drouyer M; Merjane J; Nazareth D; Knight M; Scott S; Liao SHY; Ginn SL; Zhu E; Alexander IE; Lisowski L
    Mol Ther; 2024 Mar; 32(3):818-836. PubMed ID: 38297833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
    Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
    Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
    Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
    Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of neuron-specific promoters in mouse brain transduced by intravenously administered AAV-PHP.eB.
    Radhiyanti PT; Konno A; Matsuzaki Y; Hirai H
    Neurosci Lett; 2021 Jun; 756():135956. PubMed ID: 33989730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient whole brain transduction by systemic infusion of minimally purified AAV-PHP.eB.
    Konno A; Hirai H
    J Neurosci Methods; 2020 Dec; 346():108914. PubMed ID: 32810474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier.
    Albright BH; Storey CM; Murlidharan G; Castellanos Rivera RM; Berry GE; Madigan VJ; Asokan A
    Mol Ther; 2018 Feb; 26(2):510-523. PubMed ID: 29175157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new AAV vectors with enhanced blood-brain barrier penetration efficiency
    Li M; Zhong Y; Zhu M; Pang C; Xiao L; Bu Y; Li H; Diao Y; Yang C; Liu D
    Analyst; 2024 Jul; 149(15):3980-3988. PubMed ID: 38872436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.